NEWSNATIONNOW (Steph Whiteside) - Patients sue GLP-1 makers over sudden loss of vision
Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.
JUSTTHENEWS (Ben Whedon) - JB Pritzker announces he's lost 80 lbs through GLP-1s
GLP-1s have increasingly gained prominence in recent years as effective weight-loss drugs.
YOUTUBE (CNN) - Gov. Pritzker says a GLP-1 helped him lose 80 pounds
Illinois Gov. JB Pritzker (D) revealed Monday on “CBS Mornings” that he has been taking a GLP-1 medication since he was diagnosed with diabetes two years ago.
WASHINGTONPOST (Julie Z. Weil) - Why it may become harder to get coverage for GLP-1 weight-loss drugs
For those who rely on the medications, the difference between health plans that cover them and those that don't can mean hundreds of dollars a month.
YOUTUBE (NewsNation) - Before starting a GLP‑1: do basics first
Dr. Anil Shah says patients should try to map out a healthy diet and exercise routine before turning to injections for weight loss.
NEWSNATIONNOW (Taylor Delandro) - Are GLP-1s pushing plus-size clothing off of store shelves?
Experts say there isn't enough evidence to prove weight-loss drugs are the sole reason retailers are reducing larger sizes.
YOUTUBE (NewsNation) - GLP-1 Wellness Retreats: The New Luxury Weight Loss Trend? | Hot Take with Jesse Weber
Luxury wellness retreats are being designed around people who use or are considering medications such as Ozempic, Wegovy, Mounjaro and Zepbound. Think sunrise yoga, protein-focused meals, strength training and life coaching, all for $12,000 a week. On Thursday's “Hot Take with Jesse Weber,” we break down whether these retreats provide the long-term support GLP-1 users need or whether the luxury wellness industry has found its next expensive cash cow. We'll also examine why GLP-1 use has nearly quadrupled in the past two years. Then, we're joined by Jill Boyd, COO of Hilton Head Health, one of the resorts now offering a specialized GLP-1 experience, to discuss the cost, medical oversight and value.
THENATIONALPULSE (Pulse Wires) - Medicare Launches New Weight Loss Drug Pipeline.
Medicare's first-of-its-kind weight-loss drug program has officially launched, giving American seniors access to GLP-1 drugs at a subsidized cost.
Medicare’s new weight-loss drug program offers affordable access to GLP-1 medication for seniors, marking a significant shift in healthcare coverage and efforts to combat obesity . PULSE POINTS WHAT HAPPENED: Medicare’s first-of-its-kind weight-loss drug program has officially launched, giving American seniors access to GLP-1 drugs at a subsidized cost. DETAIL: On Wednesday, Medicare & Medicaid Services launched a new program allowing Americans aged 65 and older to access weight-loss drugs at a reduced cost of $50 a month, starting with an 18-month trial period. This is the first time Medicare has offered coverage for GLP-1 weight-loss drugs, such as Novo Nordisk’s Wegovy and Eli Lilly’s Foundayo and Zepbound. Previously,…Open
NYTIMES (Dani Blum) - What Older Adults Should Know About GLP-1 Drugs as Medicare Coverage Expands
A Medicare pilot beginning Wednesday will broaden access to medications like Wegovy and Zepbound. There are unique risks for those over 65.
YOUTUBE (Newsmax) - BONUS: Dr. Jen Ashton on GLP-1s and the Future of Weight-Loss Medicine | Greta Wire
Could GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound be far more than weight-loss drugs? In this special bonus episode of Greta Wire, Greta Van Susteren is joined by Dr. Jen Ashton on NEWSMAX TV’s The Record with Greta Van Susteren to discuss a new study suggesting GLP-1 drugs may be associated with reduced cancer progression in several obesity-related cancers. Dr. Ashton explains what the study found, what it does — and does not — prove, and why researchers are now looking at GLP-1 medications for possible effects on inflammation, the immune system, cancer spread, recurrence, and prevention. Greta also presses on the insurance question: if these drugs may help prevent expensive and devastating medical complications,…